Citation

Roerecke M, Rehm J. Int. J. Epidemiol. 2014; 43(3): 906-919.

Affiliation

Centre for Addiction and Mental Health, Toronto, Canada, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada and Institut für Klinische Psychologie und Psychotherapie, Technische Universität Dresden, Dresden, Germany.

Copyright

(Copyright © 2014, International Epidemiological Association, Publisher Oxford University Press)

DOI

10.1093/ije/dyu018

PMID

24513684

Abstract

BACKGROUND:: Alcohol use disorders (AUD) are highly disabling. Recent studies reported much higher relative risks for all-cause mortality in AUD patients compared with earlier studies. Systematic evidence regarding cause-specific mortality among AUD patients has been unavailable to date.

METHODS:: Studies were identified through MEDLINE, EMBASE and Web of Science up to August 2012. Following MOOSE guidelines, prospective and historical cohort studies assessing cause-specific mortality risk from AUD patients at baseline compared with the general population were selected. Data on several study characteristics, including AUD assessment, follow-up period, setting, location and cause-specific mortality risk compared with the general population were abstracted. Random-effect meta-analyses were conducted.

RESULTS:: Overall, 17 observational studies with 6420 observed deaths among 28 087 AUD patients were included. Pooled standardized mortality ratios (SMRs) after 10 years of follow-up among men were 14.8 (95% confidence interval: 8.7-24.9) for liver cirrhosis, 18.0 (11.2-30.3) for mental disorders, 6.6 (5.0-8.8) for death by injury and around 2 for cancer and cardiovascular diseases. SMRs were substantially higher in women, with fewer studies available. For many outcomes the risk has been increasing substantially over time.

CONCLUSIONS:: Cause-specific mortality among AUD patients was high in all major categories compared with the general population. There has been a lack of recent research, and future studies should focus on the influence of comorbidities on excess mortality risk among AUD patients. Efforts to reduce these risks should be a priority, given that successful treatment reduces mortality risk substantially for a relatively common psychiatric disease.

Language: en